Jay Pepose - Apr 11, 2024 Form 4 Insider Report for Ocuphire Pharma, Inc. (OCUP)

Role
Director
Signature
/s/ Amy Rabourn, by Power of Attorney
Stock symbol
OCUP
Transactions as of
Apr 11, 2024
Transactions value $
$0
Form type
4
Date filed
4/15/2024, 04:11 PM
Previous filing
Jan 3, 2024
Next filing
Jun 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCUP Common Stock Award $0 +32K +29.82% $0.00 139K Apr 11, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCUP Stock Option (right to buy) Award $0 +48K $0.00 48K Apr 11, 2024 Common Stock 48K $1.79 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units which vest on the one-year anniversary of the grant date of April 11, 2024, subject to the Reporting Person's continuing service.
F2 The option will vest in 12 equal monthly installments beginning on May 11, 2024, subject to the Reporting Person's continuing service.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney